A Dominant-Negative c-jun Mutant Inhibits Lung Carcinogenesis in Mice
Jay W. Tichelaar(Medical College of Wisconsin), Ming You(Houston Methodist), Nancy H. Colburn(Genesis Laboratories), Hulian Yin(Cincinnati Children's Hospital Medical Center), Richard D. Estensen(Cincinnati Children's Hospital Medical Center), Yan Yan(Nanjing Agricultural University), Matthew R. Young(NYU Langone Health), Marshall W. Anderson(National Institute of Environmental Health Sciences), Qing Tan(Alvin J. Siteman Cancer Center), Yian Wang(Hunan Normal University), Colleen Goodin(Cincinnati Children's Hospital Medical Center)
Cited by 16
Related Papers
Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
|Kidney International|2018|1.4k
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
|Cell|2006|1.4k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.
|Proceedings of the National Academy of Sciences|1994|388
The 2016 global and national burden of diabetes mellitus attributable to PM 2·5 air pollution
|The Lancet Planetary Health|2018|371